- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Radiologists provide more than 'reads'
The concept that radiologists provide "reads," as opposed to professional interpretation services, is degrading to the profession and misleading to those outside of our profession. It plays into the hands of all who seek to minimize and undervalue our work.
A comment regarding the editorial by John C. Hayes, "Radiology could face disruption under 'spot market' for image reads" (September, page 5).
The concept that radiologists provide "reads," as opposed to professional interpretation services, is degrading to the profession and misleading to those outside of our profession. It plays into the hands of all who seek to minimize and undervalue our work. If we as radiologists accept this "reads" label, then we will get what we deserve-relegation to commodity status with our work farmed out to the lowest bidder.
It is contradictory to insist that we are physicians concerned with the well-being and medical care of our patients and then allow our services to be treated as an auto manufacturer (payer) might treat a car part (read) placed on a vehicle (examination) by a worker (radiologist) as it traverses an assembly line (imaging service encounter).
James B. Ball Jr., M.D.
Longwood, FL
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
